GluSense (גלוסנס)
Rehovot, Israel
GluSense is developing Glyde CGM, a miniature, implantable, continuous glucose sensor. The sensor is designed to be implanted under the skin and can transmit continuous glucose values to an external unit or smartphone for over a year, significantly improving the quality of life for patients with diabetes. The sensor is composed of a sensing unit which detects glucose and provides a glucose-dependent optical signal using a biosensor, and a detection unit which reads the optical signals and transmits the data to the external unit. GluSense is part of the Rainbow Medical innovation house.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2007
- Website
- glusensemedical.com
Categories
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of GluSense (גלוסנס)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now